Literature DB >> 15770079

Genetic polymorphisms of UGT1A6 in a Japanese population.

Mayumi Saeki1, Yoshiro Saito, Hideto Jinno, Kimie Sai, Nahoko Kaniwa, Shogo Ozawa, Kazuo Komamura, Takeshi Kotake, Hideki Morishita, Shiro Kamakura, Masafumi Kitakaze, Hitonobu Tomoike, Kuniaki Shirao, Hironobu Minami, Atsushi Ohtsu, Teruhiko Yoshida, Nagahiro Saijo, Naoyuki Kamatani, Jun-ichi Sawada.   

Abstract

Thirteen single nucleotide polymorphisms (SNPs), including 6 novel ones, were found in exon 1 and its flanking region of UDP-glucuronosyltransferase (UGT) 1A6 from 195 Japanese subjects. Several novel SNPs were identified, including 269G>A (R90H), 279A>G (S93S), and 308C>A (S103X) in exon 1, and IVS1+109C>T, IVS1+120A>G, and IVS1+142C>T in the intron downstream of exon 1. Among these SNPs, 308C>A confers termination of translation at codon 103, resulting in the production of an immature protein that probably lacks enzymatic activity. The allele frequencies were 0.003 for all the 6 SNPs. In addition, the 3 known nonsynonymous SNPs were detected: 19T>G (S7A), 541A>G (T181A), and 552A>C (R184S) with frequencies of 0.226, 0.218, and 0.226, respectively. High linkage disequilibrium was observed among 19T>G (S7A), 315A>G (L105L), 541A>G (T181A), 552A>C (R184S), and IVS1+130G>T, as reported in Caucasian and African-American populations. Then, 11 haplotypes in UGT1A6 were estimated. The novel nonsynonymous variant, 269A or 308A, was shown to be located on the same DNA strand together with 19G, 315G, 541G, 552C, and IVS1+130T. Our results provide fundamental and useful information for genotyping UGT1A6 in the Japanese, and probably Asian populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770079     DOI: 10.2133/dmpk.20.85

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  9 in total

1.  Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer.

Authors:  Folefac Aminkeng; Colin J D Ross; Shahrad R Rassekh; Michael J Rieder; Amit P Bhavsar; Shubhayan Sanatani; Daniel Bernstein; Michael R Hayden; Ursula Amstutz; Bruce C Carleton
Journal:  Br J Clin Pharmacol       Date:  2017-03-19       Impact factor: 4.335

2.  Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients.

Authors:  Xiao-Man Chu; Li-Fang Zhang; Guang-Ji Wang; Shen-Ning Zhang; Jia-Hui Zhou; Hai-Ping Hao
Journal:  Eur J Clin Pharmacol       Date:  2012-04-05       Impact factor: 2.953

3.  Pharmacogenetics of irinotecan: An ethnicity-based prediction of irinotecan adverse events.

Authors:  Shouji Shimoyama
Journal:  World J Gastrointest Surg       Date:  2010-01-27

4.  Renin-angiotensin system associated with risk of upper GI mucosal injury induced by low dose aspirin: renin angiotensin system genes' polymorphism.

Authors:  Akiko Shiotani; Ryuji Nishi; Yoshiyuki Yamanaka; Takahisa Murao; Hiroshi Matsumoto; Ken-ichi Tarumi; Tomoari Kamada; Takashi Sakakibara; Ken Haruma
Journal:  Dig Dis Sci       Date:  2010-09-08       Impact factor: 3.199

5.  UDP-glucuronosyltransferases mediate coffee-associated reduction of liver fibrosis in bile duct ligated humanized transgenic UGT1A mice.

Authors:  Steffen Landerer; Sandra Kalthoff; Christian P Strassburg
Journal:  Hepatobiliary Surg Nutr       Date:  2021-12       Impact factor: 7.293

6.  The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy.

Authors:  Akiko Shiotani; Takashi Sakakibara; Yoshiyuki Yamanaka; Ryuji Nishi; Hiroshi Imamura; Minoru Fujita; Ken-ichi Tarumi; Tomoari Kamada; Jiro Hata; Ken Haruma
Journal:  J Gastroenterol       Date:  2009-05-16       Impact factor: 7.527

7.  UGT1A6 genotype-related pharmacokinetics of deferiprone (L1) in healthy volunteers.

Authors:  Lie Michael George Limenta; Totsapol Jirasomprasert; Jeeranut Tankanitlert; Saovaros Svasti; Prapin Wilairat; Udom Chantharaksri; Suthat Fucharoen; Noppawan Phumala Morales
Journal:  Br J Clin Pharmacol       Date:  2008-03-03       Impact factor: 4.335

8.  Association of UGT1A6 gene polymorphism with clinical outcome in pediatric epileptic patients on sodium valproate monotherapy.

Authors:  N Banawalikar; S Adiga; U Adiga; V Shenoy; S Kumari; P Shetty; S Shetty; K P Sharmila
Journal:  Braz J Med Biol Res       Date:  2021-06-14       Impact factor: 2.590

9.  UGT1A6 polymorphisms modulated lung cancer risk in a Chinese population.

Authors:  Ley-Fang Kua; Soo Ross; Soo-Chin Lee; Kousaku Mimura; Koji Kono; Boon-Cher Goh; Wei-Peng Yong
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.